Skip to main content

Table 2 Short-term outcomes of matched non-training case and training case colorectal cancer resections

From: Supervised training of laparoscopic colorectal cancer resections does not adversely affect short- and long-term outcomes: a Propensity-score-matched cohort study

Ā 

Non-training cases (n=95)

Training cases (n=95)

p

OR (95% CI)c

Operation time in minutes (median, range)

160 (70ā€“420)

180 (30ā€“360)

0.072a

Ā 

Blood loss in ml (median, range)

10 (0ā€“500)

10 (0ā€“200)

0.224a

Ā 

Conversion

Ā Ā 

0.497b

5.40(0.24ā€“107)

ā€ƒNo

95 (100%)

93 (97.9%)

Ā 

ā€ƒYes

0 (0%)

2 (2.1%)

Ā 

Length of stay in days (median, range)

5 (2ā€“29)

4 (2ā€“30)

0.751a

Ā 

30-day mortality

Ā Ā 

0.497b

0.33 (0.01ā€“8.2)

ā€ƒNo

94 (98.9%)

95 (100%)

Ā 

ā€ƒYes

1 (1.1%)

0 (0%)

Ā 

Readmission

Ā Ā 

0.795b

0.76 (0.28ā€“2.10)

ā€ƒNo

86 (90.5%)

88 (92.6%)

Ā 

ā€ƒYes

9 (9.5%)

7 (7.4%)

Ā 

Complications

Ā Ā 

0.097b

0.66 (0.32ā€“1.38)

ā€ƒNo complications (without mortality)

74 (77.9%)

80 (84.2%)

Ā 

ā€ƒMinor leak

6 (6.3%)

3 (3.2%)

Ā 

ā€ƒMajor leak

2 (2.1%)

0 (0.0%)

Ā 

ā€ƒProlonged ileus

3 (3.2%)

1 (1.1%)

Ā 

ā€ƒProlonged pain

4 (4.2%)

0 (0.0%)

Ā 

ā€ƒWound infection

0 (0.0%)

5 (5.3%)

Ā 

ā€ƒAbdominal sepsis

1 (1.1%)

1 (1.1%)

Ā 

ā€ƒHigh stoma output

1 (1.1%)

1 (1.1%)

Ā 

ā€ƒStoma fashioning

1 (1.1%)

2 (2.1%)

Ā 

ā€ƒBleeding

1 (1.1%)

1 (1.1%)

Ā 

ā€ƒUrinary tract affection

1 (1.1%)

1 (1.1%)

Ā 

ā€ƒMedical condition

1 (1.1%)

0 (0.0%)

Ā 

Reoperation

Ā Ā 

1.000b

0.49 (0.08ā€“5.54)

ā€ƒNo

93 (97.3%)

94 (98.9%)

Ā 

ā€ƒYes

2 (2.1%)

1 (1.1%)

Ā 

Clavienā€“Dindo graded complications

Ā Ā 

0.068b

0.74 (0.38ā€“1.46)

ā€ƒNo complications

70 (73.7%)

75 (78.9%)

Ā 

ā€ƒ1

2 (2.1%)

9 (9.5%)

Ā 

ā€ƒ2

17 (17.9%)

9 (9.5%)

Ā 

ā€ƒ3a

2 (2.1%)

1 (1.1%)

Ā 

ā€ƒ3b

2 (2.1%)

1 (1.1%)

Ā 

ā€ƒ4a

0 (0.0%)

0 (0.0%)

Ā 

ā€ƒ4b

1 (1.1%)

0 (0.0%)

Ā 

ā€ƒ5

1 (1.1%)

0 (0.0%)

Ā 

Major complications (ā‰„3b)

Ā Ā 

0.368b

0.29 (0.03ā€“2.21)

ā€ƒNo

91 (95.8%)

94 (98.9%)

Ā 

ā€ƒYes

4 (4.2%)

1 (1.1%)

Ā 

R stage

Ā Ā 

0.444b

0.39 (0.07ā€“2.05)

ā€ƒR0

90 (94.7%)

93 (97.9%)

Ā 

ā€ƒR1 or R2

5 (5.3%)

2 (2.1%)

Ā 

Lymph node harvest (median, range)

17 (5ā€“56)

15 (3ā€“48)

0.057a

Ā 
  1. aMannā€“Whitney U test, bFisherā€™s exact test, codds ratio (OR) with 95% confidence intervals (95% CI) calculated according to Altmann 1991